Citation:Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, et al 2015

From Cancer Guidelines Wiki

Citation


Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol 2015 Feb;16(2):187-99 Available from: http://www.ncbi.nlm.nih.gov/pubmed/25601342.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What is the recommended treatment approach for the definitive management of patients with good performance status and inoperable stage III disease?
What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy?
What are the principles of radiation therapy in the definitive management of stage III inoperable NSCLC?
Dr Margot Lehman MBBS FRANZCR GDPcompleted
What is the optimal chemotherapy regime in concurrent chemo-radiotherapy in inoperable stage III NSCLC?Dr Adelaide Morgancompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the recommended treatment approach for the definitive management of patients with good performance status and inoperable stage III disease?, Clinical question:What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy?, Clinical question:What are the principles of radiation therapy in the definitive management of stage III inoperable NSCLC?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the recommended treatment approach for the definitive management of patients with good performance status and inoperable stage III disease?</span>, <span class="smw-value">Clinical question:What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy?</span>, <span class="smw-value">Clinical question:What are the principles of radiation therapy in the definitive management of stage III inoperable NSCLC?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the optimal chemotherapy regime in concurrent chemo-radiotherapy in inoperable stage III NSCLC?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the optimal chemotherapy regime in concurrent chemo-radiotherapy in inoperable stage III NSCLC?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy?